Medicare Enrolled
Dr. Martin Palmeri, M.D.,M.B.A.
Hematology · Asheville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Palmeri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Palmeri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Palmeri
Dr. Martin Palmeri is a hematology specialist in Asheville, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Palmeri performed 63,669 Medicare services across 3,458 unique beneficiaries.
Between the years covered by Open Payments, Dr. Palmeri received a total of $12,731 from 46 pharmaceutical and/or device companies across 164 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Palmeri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in NC
$12,731 industry payments
Medicare Practice Summary
Medicare Utilization ↗63,669
Medicare services
Top 11% in NC for hematology
3,458
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,351 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
14,236 | $0 | $18 |
| Anti-nausea injection (aprepitant) | 10,140 | $1 | $6 |
| Pembrolizumab injection (Keytruda) | 8,500 | $43 | $157 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
5,610 | $0 | $4 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,800 | $0 | $1 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
3,600 | $38 | $136 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,510 | $6 | $25 |
| Denosumab injection (Prolia/Xgeva) | 1,740 | $18 | $64 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,238 | $0 | $1 |
| Iron infusion (Monoferric) | 1,200 | $16 | $74 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,181 | $8 | $29 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,089 | $36 | $141 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,026 | $8 | $9 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
980 | $4 | $135 |
| Anti-nausea injection (Aloxi/palonosetron) | 930 | $1 | $41 |
| Injection, leucovorin calcium, per 50 mg | 770 | $3 | $14 |
| Anti-nausea injection (ondansetron/Zofran) | 600 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
527 | $92 | $390 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
499 | $2 | $7 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 402 | $3 | $42 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
371 | $94 | $421 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
216 | $81 | $654 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
188 | $21 | $103 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
180 | $129 | $550 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
176 | $10 | $67 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
161 | $71 | $210 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
147 | $63 | $277 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
124 | $11 | $66 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
113 | $59 | $214 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
77 | $45 | $180 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
71 | $88 | $308 |
| New patient office visit, complex (60-74 min) | 70 | $155 | $673 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
69 | $7 | $126 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
68 | $46 | $208 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
66 | $21 | $164 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
66 | $1 | $4 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
65 | $52 | $234 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 61 | $137 | $603 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
56 | $2 | $9 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
54 | $23 | $135 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
50 | $9 | $40 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
49 | $3 | $11 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
49 | $17 | $83 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
48 | $46 | $205 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
48 | $1 | $6 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
42 | $176 | $613 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
41 | $14 | $63 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 41 | $196 | $1,533 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
37 | $15 | $65 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
34 | $41 | $177 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
33 | $55 | $368 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
30 | $23 | $105 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
28 | $171 | $733 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
27 | $132 | $595 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
25 | $1,081 | $4,447 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
21 | $4 | $12 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
19 | $87 | $316 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
18 | $1,082 | $4,447 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
18 | $28 | $121 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
18 | $1 | $21 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
16 | $67 | $313 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.7% high complexity
80.1% medium
6.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,731
Total received (2020-2024)
Avg $2,546/year across 5 years
Top 23% in NC for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
164
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,698 (36.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,183 (32.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,849 (30.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,151
2023
$2,813
2022
$5,507
2021
$232
2020
$27
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BeiGene USA, Inc.
$1,894
SERVIER PHARMACEUTICALS LLC
$962
Janssen Biotech, Inc.
$619
Novartis Pharmaceuticals Corporation
$119
Celgene Corporation
$74
Daiichi Sankyo Inc.
$57
E.R. Squibb & Sons, L.L.C.
$55
Eisai Inc.
$48
Incyte Corporation
$41
Myriad Genetic Laboratories, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$24
ABBVIE INC.
$24
Regeneron Healthcare Solutions, Inc.
$23
Exelixis Inc.
$22
Merck Sharp & Dohme LLC
$21
Acrotech Biopharma Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$19
Genentech USA, Inc.
$19
ARRAY BIOPHARMA INC
$18
Astellas Pharma US Inc
$18
Adaptive Biotechnologies Corporation
$15
PFIZER INC.
$14
Alexion Pharmaceuticals, Inc.
$13
Top 3 companies account for 83.7% of 2024 payments
All-time payments by company (2020-2024) ›
Karyopharm Therapeutics Inc.
$2,469
BeiGene USA, Inc.
$1,952
Rigel Pharmaceuticals, Inc.
$1,184
Incyte Corporation
$1,151
Veracyte, Inc.
$994
SERVIER PHARMACEUTICALS LLC
$962
Daiichi Sankyo Inc.
$947
Janssen Biotech, Inc.
$811
Novartis Pharmaceuticals Corporation
$280
PFIZER INC.
$222
E.R. Squibb & Sons, L.L.C.
$218
Eisai Inc.
$170
Celgene Corporation
$133
Mirati Therapeutics, Inc.
$104
AstraZeneca Pharmaceuticals LP
$97
Amgen Inc.
$93
Takeda Pharmaceuticals U.S.A., Inc.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$60
Seagen Inc.
$59
Deciphera Pharmaceuticals Inc.
$58
ARRAY BIOPHARMA INC
$47
Regeneron Healthcare Solutions, Inc.
$46
Astellas Pharma US Inc
$41
Lilly USA, LLC
$41
AVEO Pharmaceuticals, Inc.
$41
Exelixis Inc.
$40
Adaptive Biotechnologies Corporation
$39
Merck Sharp & Dohme Corporation
$37
Myriad Genetic Laboratories, Inc.
$31
Alexion Pharmaceuticals, Inc.
$27
ABBVIE INC.
$24
Gilead Sciences, Inc.
$24
EISAI INC.
$22
G1 Therapeutics, Inc.
$22
AbbVie Inc.
$22
Merck Sharp & Dohme LLC
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Tactile Systems Technology Inc
$20
GENZYME CORPORATION
$19
Acrotech Biopharma Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$19
Genentech USA, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
Puma Biotechnology, Inc.
$16
ADC Therapeutics America, Inc.
$15
Kyowa Kirin, Inc.
$15
Top 3 companies account for 44.0% of all-time payments
Associated products mentioned in payments ›
BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CREON · DARZALEX · ELIQUIS · ENHERTU · ERLEADA · Enhertu · FOTIVDA · FRUZAQLA · Flexitouch Plus · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUTATHERA · Lenvima · MYRISK · NINLARO · Nplate · OPDIVO · OPDUALAG · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Stivarga · TECVAYLI · TEVIMBRA · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · VERZENIO · Venclexta · XALKORI · XPOVIO · XTANDI · Xospata · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (37%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Hematologists within 10 mi
10
Per 100K population
3.7
County median income
$70,578
Nearest hospital
MEMORIAL MISSION HOSPITAL AND ASHEVILLE SURGERY CE
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Palmeri is a mixed practice specialist, with above-average Medicare volume (top 11% in NC), with mixed engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Palmeri experienced with oxaliplatin chemotherapy injection?
Based on Medicare claims data, Dr. Palmeri performed 14,236 oxaliplatin chemotherapy injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Palmeri receive payments from pharmaceutical companies?
Yes. Dr. Palmeri received a total of $12,731 from 46 companies across 164 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Palmeri's costs compare to other hematologists in Asheville?
Dr. Palmeri's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Palmeri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Asheville
Browse hematologists in Asheville ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in NC
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in NC
Which NC hematologists receive the most from drug and device companies.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology